Delivery Order SPE2DB24D2101-SPE2DB25FKLRA

Award Date 6/23/25
Potential Completion Date 7/15/25
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $11,448.50 delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of VENCLEXTA 100 MG TABLET UU 28S, a pharmaceutical product. The contract is a Firm Fixed Price arrangement with a performance period through June 20, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a $19,456.34 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 100 mg Venclexta tablets. The contract is a firm fixed-price arrangement with a period of performance through July 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VENCLEXTA 100 MG TABLET, a medication, with a firm fixed price of $9,728.17 and a period of performance through July 8, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VENCLEXTA 100 MG TABLET UU 120S. The contract has a firm fixed price of $9,728.17 and a performance period ending on July 16, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VENCLEXTA 100 MG TABLET UU 120S, a specialty pharmaceutical product. The order has a potential value of $26,640.45 and a completion date of March 19, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA as the primary vehicle for delivering pharmaceutical products...
This is a $8,880.15 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The award is for the supply of 4,565,266,344 units of the prescription drug VENCLEXTA 100 mg tablets. The contract has an ultimate completion date of August 16, 2024 and was awarded on July 26, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,728.17, is for the delivery of VENCLEXTA 100 MG TABLET UU 120S, a prescription medication. The contract has an ultimate completion date of July 15, 2025 and was awarded on June 23, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $11,826.42 and is for the delivery of Venclexta 100 mg tablets. It is a firm-fixed-price contract with a completion date of June 13, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corporation holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,162.04 firm fixed-price contract is for the delivery of the prescription medication VENCLEXTA 50 MG TABLET UD 7S. The award does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of June 9, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VENCLEXTA 100 MG TABLET, a prescription medication, with a ceiling value of $9,728.17 and an ultimate completion date of July 14, 2025. The contract is a Firm Fixed Price Delivery Order and is not set aside for any special designations. Amerisourcebergen Drug Corp holds a significant...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB25FKLRA
    Delivery Order

This is a $19,456.34 delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of VENCLEXTA 100 MG TABLET in quantities of 120 tablets, with a completion date of July 15, 2025. The contract is a firm fixed-price, non-set-aside award.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/28/25, 1:53 AM